Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 3, 2021Open Access

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

View Full Paper
Ask AI
Bookmark
Share

Authors

VSVivek ShindeTata Motors (India)SBSutika BhikhaSouth African Medical Research CouncilZHZaheer HoosainClinvet

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shinde et al. (2021) studied this question.

synapsesocial.com/papers/6ab4a793c00cd19ff64d3cf3https://doi.org/10.1101/2021.02.25.21252477
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa2021 · 122 citations
  2. 2A Modified Poisson Regression Approach to Prospective Studies with Binary Data2004 · 9,834 citations
  3. 3Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 15,758 citations
  4. 4Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding2020 · 2,267 citations
  5. 5Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma2021 · 151 citations